Stephen Taub Premium Biopharma Hedge Funds Rebounded Sharply Last Month — But Is It Sustainable? Acquisitions and breakthroughs lifted biotech funds in August, with Avoro and RTW posting double-digit gains. Stephen Taub September 11, 2025